At the last check on Thursday, Humana Inc.’s (NYSE:HUM) stock was down -$4.6, moving down -0.93 percent to $490.06. The average number of shares traded per day over the past five days has been 707,273 shares. 2 times new highs have been achieved over the past 5 days, with a -$4.10 fall in that time frame. In the last twenty days, the average volume was 1,387,113, while in the previous 50 days, it was 1,652,761.
Since last month, HUM stock rose 9.57%. Shares of the company fell to $432.76 on 07/18/23, the lowest level in the past month. A 52-week high of $571.30 was reached on 05/09/23 after having rallying from a 52-week low of $423.29. Since the beginning of this year, HUM’s stock price has dropped by -4.32% or -$21.26, and marked a new high 8 times. However, the stock has declined by -14.22% since its 52-week high.
HUM stock investors should be aware that Humana Inc. (HUM) stock had its last reported insider trading activity 105 days ago on May 04. Diamond Susan M, the Chief Financial Officer of the company, disposed of 4,156 shares for $526.28 on May 04. It resulted in a $2,187,226 divestment by the insider. BROUSSARD BRUCE D sold 17,575 shares at an average price of $505.85 on Feb 27. The insider now owns 70,040 shares following the transaction. On Feb 27, Chief Administrative Officer Huval Timothy S. sold 2,628 shares at $510.30 apiece. The transaction was valued at $1,341,080.
Valuation Metrics
Right now, Humana Inc. (HUM) has a P/E ratio of about 18.29. The stock’s beta is 0.64. Besides these, the trailing price-to-sales (P/S) ratio of 0.62, the price-to-book (PB) ratio of 3.63, and the price-to-cash flow ratio of 5.01 may also be considered.
The latest dividend of $0.8850 per share was paid out, remained unchanged from last year’s $0.8850. On Thursday February 16 2023, a $0.0975 dividend increase was announced.
Financial Health
According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.58, and the total debt-to-equity ratio was 0.72. In the year ended June 29, operating margins totaled 4.70%. Based on annual data, HUM earned $17.18 billion in gross profit and brought in $92.87 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 12.20%. Return on equity (ROE) for the past 12 months was 20.80%.
In Humana Inc.’s quarter-end financial report for June 29, it reported total debt of $9.72 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. HUM’s revenue rose 11.53% to $26.74 billion during the quarter, while net income inched up to $26.75 billion. While analysts expected Humana Inc. to report $8.82 quarterly earnings, the actual figure was $8.94 per share, beating the consensus estimate by 1.40%. During the quarter, the company generated $1.66 billion in EBITDA. The liabilities of Humana Inc. were 39.56 billion at the end of its most recent quarter ended June 29, and its total debt was $12.2 billion. The value of shareholders’ equity is $123.91 million.
Technical Picture
This quick technical analysis looks at Humana Inc.’s (HUM) price momentum. With a historical volatility rate of 12.61%, the RSI 9-day stood at 64.69% on 16 August.
With respect to its five-day moving average, the current Humana Inc. price is down by -0.83% percent or -$4.10. At present, HUM shares trade +9.73% above its 20-day simple moving average and -2.29% percent below its 100-day simple moving average. However, the stock is currently trading approximately -3.95% below its SMA50 and -11.52% below its SMA200.
Stochastic coefficient K was 87.01% and Stochastic coefficient D was 89.86%, while ATR was 8.01. Given the Stochastic reading of 80.69% for the 14-day period, the RSI (14) reading has been calculated as 63.71%. As of today, the MACD Oscillator reading stands at -0.62, while the 14-day reading stands at 6.60.
Analyst Ratings
Humana Inc. downgraded its rating on Humana Inc. (NYSE: HUM) to a Neutral in a note to investors on July 07, 2023. The analysts firm previously had an Overweight rating on the stock.Humana Inc. (HUM) has been rated Overweight by analysts. According to 0 brokerage firms, HUM is a sell, and 5 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Humana Inc. stock as buy, with 16 recommending it as overweight.
With a median target price of $589.00, the current consensus forecast for the stock is $468.00 – $640.00. Based on these forecasts, analysts predict Humana Inc. (HUM) will achieve an average price target of $584.05.
